Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-50.47	66.56	134.39
Graham Fair Price	30.06	0.07	0.05
PEG	-39.60	-2.90	4.80
Price/Book	14.08	1.58	1.38
Price/Cash Flow	41.16	-50.88	-86.47
Prices/Earnings	42.96	-289.96	-508.33
Price/Sales	-43.00	16.77	29.41
Price/FCF	41.16	-50.88	-86.47
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	42.34	0.77	0.54
Operating Margin	12.72	0.21	0.19
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-100.00
ROIC	< 0.005	< 0.005	-125.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	1.60	0.90	76.41
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.22	1.26	469.93
EPS QOQ	-1.06	-1.00	5.56
FCF QOQ	0.43	-0.94	119.60
Revenue QOQ	-0.46	1.00	115.98
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	209.43	209.43	0.00
Days Sales Outstanding (DSO)	-0.19	567.51	294236.13
Inventory Turnover	0.43	0.43	0.00
Debt/Capitalization	< 0.005	< 0.005	159.36
Quick Ratio	0.55	4.05	631.19
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.44	0.41	-8.03
Cash	0.04	0.04	-8.57
Capex	< 0.005	< 0.005	-83.93
Free Cash Flow	< 0.005	-0.01	-78.31
Revenue	0.02	0.04	84.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.70	2.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.67	-4.12	57.39
Naive Interpretation	Member

06 - Financial Health · Bad

Rating